Clinical trial
Clinical Evaluation of BW430C in Epilepsy<Phase III Study>
NCT00395694 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Evaluation of BW430C in Epilepsy<Phase III Study>
- Lead sponsor
- GlaxoSmithKline
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- August 7, 2006
- Completion date
- March 26, 2009
- Enrollment
- 102 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.